See All Resources
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
Go to Resource
Share:
Link is copied!
Orginally Published:
June, 01 2016
To access this material, you must be an IC-OS member. Become an IC-OS Member today
